Polymeropoulos Mihael Hristos
SEC insider (Form 3/4/5 filer). CIK 0001355537. President and CEO at Vanda Pharmaceuticals Inc. (VNDA). 18 reported Form 4/5 transactions since Sep 2024; latest on Mar 2, 2026. Located in WASHINGTON, DC.
Companies Polymeropoulos Mihael Hristos has filed insider reports for
- Vanda Pharmaceuticals Inc. (VNDA): Director, Officer, President and CEO
Polymeropoulos Mihael Hristos
CIK: 0001355537
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Vanda Pharmaceuticals Inc.
Discretionary Trading P&L
Holdings
Transaction History (18 total)
- Mar 2, 2026VNDA
Vanda Pharmaceuticals Inc.
SaleDirect156.2K shares at avg. $8.17$1.3M - Feb 18, 2026VNDA
Vanda Pharmaceuticals Inc.
AwardDirect525K shares- - Aug 7, 2025VNDA
Vanda Pharmaceuticals Inc.
PurchaseDirect10K shares at avg. $4.15$42K - May 21, 2025VNDA
Vanda Pharmaceuticals Inc.
PurchaseDirect9.5K shares at avg. $4.40$42K - May 21, 2025VNDA
Vanda Pharmaceuticals Inc.
PurchaseDirect481 shares at avg. $4.39$2K - May 16, 2025VNDA
Vanda Pharmaceuticals Inc.
PurchaseDirect20K shares at avg. $4.22$84K - Mar 6, 2025VNDA
Vanda Pharmaceuticals Inc.
PurchaseDirect5K shares at avg. $5.01$25K - Mar 6, 2025VNDA
Vanda Pharmaceuticals Inc.
PurchaseDirect5K shares at avg. $5.02$25K - Mar 5, 2025VNDA
Vanda Pharmaceuticals Inc.
PurchaseDirect5K shares at avg. $5.01$25K - Mar 5, 2025VNDA
Vanda Pharmaceuticals Inc.
PurchaseDirect5K shares at avg. $5.03$25K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Mar 2, 2026 | VNDA Vanda Pharmaceuticals Inc. | Sale | 156,235 | $8.17 | $1,276,971 | Direct |
| Feb 18, 2026 | VNDA Vanda Pharmaceuticals Inc. | Award | 525,000 | - | $0 | Direct |
| Aug 7, 2025 | VNDA Vanda Pharmaceuticals Inc. | Purchase | 10,000 | $4.15 | $41,500 | Direct |
| May 21, 2025 | VNDA Vanda Pharmaceuticals Inc. | Purchase | 9,519 | $4.40 | $41,884 | Direct |
| May 21, 2025 | VNDA Vanda Pharmaceuticals Inc. | Purchase | 481 | $4.39 | $2,112 | Direct |
| May 16, 2025 | VNDA Vanda Pharmaceuticals Inc. | Purchase | 20,000 | $4.22 | $84,472 | Direct |
| Mar 6, 2025 | VNDA Vanda Pharmaceuticals Inc. | Purchase | 5,000 | $5.01 | $25,050 | Direct |
| Mar 6, 2025 | VNDA Vanda Pharmaceuticals Inc. | Purchase | 5,000 | $5.02 | $25,100 | Direct |
| Mar 5, 2025 | VNDA Vanda Pharmaceuticals Inc. | Purchase | 5,000 | $5.01 | $25,050 | Direct |
| Mar 5, 2025 | VNDA Vanda Pharmaceuticals Inc. | Purchase | 5,000 | $5.03 | $25,150 | Direct |
1-10 of 18 transactions